Pharma areas of interest

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

We focus on chronic diseases, HBV, influenza and MDR antibacterials.

We focus on neurodegeneration, psychiatry, and neurodevelopmental disorders.

We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.

We create and maintain an independent network of R&D centres.

We focus on therapeutic modalities and enabling technologies.

If you have an idea, we would like to hear from you.